<DOC>
	<DOCNO>NCT00143481</DOCNO>
	<brief_summary>The purpose study assess impact treatment tolterodine ER versus placebo Urgency Urinary Incontinence sexually active woman OAB symptom .</brief_summary>
	<brief_title>Effect Detrol LA Overactive Bladder Symptoms , Sexual Quality Life Sexual Function Women</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Female outpatient 18 year old . Overactive bladder symptom ( subjectreported ) great equal 3 month . Currently sexually active male partner . Diagnosed suspected interstitial cystitis , uninvestigated hematuria , urogenital cancer , interstitial external radiation pelvis external genitalia clinically significant bladder outlet obstruction . Symptoms incontinence predominately stress urinary incontinence determine investigator . Treated antimuscarinic/ anticholinergic medication , reason include OAB , within last 3 month expect start therapy study treatment period . Any drug urgency urinary incontinence ( UUI ) initiate within past 3 month prior Visit 1 , exception estrogen ( topical systemic ) long treatment initiate within 4 week prior Visit 1 ( screen )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>